PMC:7600245 / 49856-49982
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T494 | 6-7 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T7933 | 8-16 | Chemical | denotes | biphenyl | http://purl.obolibrary.org/obo/CHEBI_17097 |
| T40831 | 17-26 | Chemical | denotes | carbamoyl | http://purl.obolibrary.org/obo/CHEBI_23004|http://purl.obolibrary.org/obo/CHEBI_33100 |
| T2210 | 27-39 | Chemical | denotes | cyclopentene | http://purl.obolibrary.org/obo/CHEBI_49155 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T372 | 0-126 | Sentence | denotes | It is a biphenyl-carbamoyl-cyclopentene derivative (Figure 7) that is being developed as oral formulation for therapeutic use. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 1568 | 8-39 | Chemical | denotes | biphenyl-carbamoyl-cyclopentene |